Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-02-09 @ 9:57 AM
Study NCT ID:
NCT00349934
Status:
COMPLETED
Last Update Posted:
2010-01-07
First Post:
2006-07-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma
Sponsor:
Immutep S.A.S.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Breast Cancer | View |